Developer docs
API playgroundTry for free, no card

Search company profiles

Sonara Health

Full company profile

uuid0000az3

Namestring
Sonara Health
Legal namestring
Sonara Health, Inc.
Company typeenum
Private
Founded yearint
2020
Descriptiontext

Sonara Health is a Dallas-based healthcare technology company founded in 2020 that operates a HIPAA-compliant, FDA Class I-registered telehealth platform enabling remote observed dosing of methadone for patients with opioid use disorder (OUD). The platform combines a patented tamper-evident medication label with a patient-facing web application (Virtual Dosing Window™), a clinician dashboard for asynchronous video review and adherence tracking, and a suite of hybrid care tools (telecounseling, secure messaging, remote intake). An optional Measurement-Based Care (MBC) module supports structured clinical decision-making and is being validated through NIDA-funded research.

The company's primary customers are federally-licensed Opioid Treatment Programs (OTPs), which subscribe to the platform to issue take-home methadone doses with remote clinical oversight rather than requiring daily in-person visits. Sonara's distribution is anchored by channel partnerships with the largest U.S. OTP chains — including Behavioral Health Group, BayMark Health Services, Community Medical Services, and MedMark — alongside direct sales to individual clinics, and is increasingly supported by payer- and state-government-funded deployment models using Medicaid MCO contracts (CareSource), state opioid settlement funds (Pennsylvania, New Jersey FY25 budget), and grants.

Sonara generates revenue primarily through multi-year SaaS subscriptions sold to OTPs on a quote-based enterprise pricing model, augmented by grant and payer-funded deployment arrangements. The company has raised approximately $10.9M in equity across multiple rounds between 2021 and 2025 from impact-oriented investors including Mark Cuban, Acumen America, First Trust Capital Partners, Boomerang Ventures, and Blue Cross Blue Shield of Kansas, plus $2.5M in non-dilutive NIDA SBIR funding. Operational scale as of late 2024–early 2025 includes 40+ OTP locations across 14 states, 200,000+ cumulative methadone doses recorded on the platform, and a reported 30x revenue increase since launch.

Short descriptiontext

Sonara Health operates a HIPAA-compliant, FDA Class I-registered telehealth platform that enables opioid treatment programs (OTPs) to remotely observe methadone dosing for patients with opioid use disorder. The patented tamper-evident system allows OTPs to safely expand take-home dosing, currently deployed at 40+ sites across 14 states via partnerships with major OTP chains and state-government funding.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersDallas, United States
HQ citystring
Dallas
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
opioid treatment platform, methadone remote dosing, telehealth medication monitoring, addiction treatment software, hybrid care platform
Industry3 codes
PRIMARYHLAFACAG
Medication-Assisted Treatment (MAT) & Opioid Treatment Programs (OTPs)
Healthcare & Life Sciences/Healthcare Providers & Systems/Behavioral Health & Substance Use Treatment
SECONDARYHLACAFAD
Behavioral Health & Substance Use Remote Monitoring
Healthcare & Life Sciences/Digital Health & Health IT/Remote Patient Monitoring (RPM) & Connected Care Platforms
SECONDARYHLALAIAM
Controlled-Substance & High-Risk Medication Teleprescribing Platforms (compliance-focused)
Healthcare & Life Sciences/Telehealth Platforms/Pharmacy-Integrated Telehealth & ePrescribing Platforms
NAICS code2 codes
  • Outpatient Mental Health and Substance Abuse Centers621420
  • Offices of Physicians6211
SIC code1 code
  • Services-Health Services8000
Product category
Opioid Treatment Software
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model2 records
1SaaS Platform Subscription
TypeSubscription Recurring
Description

Sonara provides its remote medication monitoring platform to OTPs on a subscription basis. OTPs pay for access to the platform to enable their patients to record take-home methadone doses remotely. Revenue is recurring as OTPs subscribe to use the platform for their patient population.

sonarahealth.com
2Partnership Funding
TypeManaged Services
Description

Sonara partners with healthcare payers (CareSource) and state governments (New Jersey) to fund platform deployment at partner OTPs, particularly using opioid settlement funds. This creates alternative revenue streams through grants and payer contracts.

sonarahealth.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Personnel, Marketing or Sales, Operations, Infrastructure
Pricing details1 tier
1Enterprise pricing for OTP partners - quote-based
ModelSubscriptionBilling cadenceMulti-year contract
Notes

Platform pricing appears to be subscription-based for opioid treatment programs. Specific pricing tiers not publicly disclosed. Costs for OTPs may be funded through opioid settlement funds, Medicaid partnerships (CareSource), or state grants.

sonarahealth.com
GTM typeB2B
B2B
Offering typeSoftware
Software
Core offering1 text field

Sonara Health develops a HIPAA-compliant, FDA Class I Medical Device telehealth platform that enables federally-licensed opioid treatment programs (OTPs) to remotely observe and verify patient self-administration of methadone at home. The platform combines a patient-facing Virtual Dosing Window app (QR code scanning plus video recording of each dose), a clinician dashboard for asynchronous adherence review, and hybrid care tools (telecounseling, secure messaging, remote intake) to reduce daily in-person clinic visits while maintaining regulatory compliance.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 7 values shown
  • 85% of take-home methadone doses taken as prescribed on platform
+6 more records
Product overview1 text field

Sonara Health offers a hybrid care platform for opioid treatment programs (OTPs) consisting of three integrated core products: the Virtual Dosing Window™ (patient-facing app for remote methadone dosing via QR scanning and video recording), Hybrid Care Tools (telehealth suite including remote intake, telecounseling, and messaging), and the Clinician Platform (care team dashboard for video review and patient monitoring). The platform includes a patented tamper-aware medication adherence system with QR codes, enabling patients to record methadone doses at home while care teams review remotely. An optional Measurement-Based Care (MBC) tool integrates assessment capabilities. The complete system is available via the sonara.app portal.

Product and service2 records
1Virtual Dosing Window™
CategoryTelehealth / Remote Medication Monitoring
Description

Patient-facing web application that enables individuals in methadone treatment programs to record their daily methadone dose from home. Patients scan a tamper-aware QR code on their medication bottle and record a short video of themselves taking the dose, which is sent to their OTP care team for asynchronous review. Designed for opioid treatment programs (OTPs) and their patients with opioid use disorder.

2Clinician Platform
Scale indicator7 records

Each record includes

Type, Value, Description, Source

Partnership11 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-03-07
Description

MedMark's Washington clinic partnership expanded to Pennsylvania using state opioid settlement funds. Partnership makes remote dosing platform available to Pennsylvania patients.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2024-05-07
Description

CMS operates 73 clinics across 11 states treating 24,000 patients daily. Partnership makes Sonara available at four CMS clinics in Ohio (Cleveland, Lima, Columbus, Kettering), funded by CareSource.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2024-03-11
Description

BayMark operates opioid treatment programs across multiple states. Partnership enables Sonara's remote dosing platform at BayMark Ohio clinics. Dave White, BayMark CEO, noted the partnership enables safe take-home dosing for patients.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2024-03-11
Description

Nonprofit health plan that provided funding to enable Sonara deployment at BayMark Ohio clinics. CareSource is a Medicaid managed care organization committed to addressing gaps in behavioral health care for members.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2024-01-29
Description

Treatment center operating since 1983 in Orlando area. Partnership makes Sonara the 10th state for remote dosing platform availability.

6SouthEast Alaska Regional Health Consortium (SEARHC)
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2024-01-22
Description

One of the largest Native-run healthcare organizations in the US serving 27 communities in Southeast Alaska. Partnership brings Sonara to eligible patients in Klawock, Sitka, and Juneau.

sonarahealth.com
7New Jersey Association for the Treatment of Opioid Dependence (NJATOD)
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2024-01-01
Description

Partnership with NJATOD and Assemblyman William F. Moen Jr. to administer state-funded remote observation pilot program for take-home methadone included in NJ FY25 budget.

sonarahealth.com
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2023-12-28
Description

BHG operates the largest network of Joint Commission-accredited OTPs in 22 states. Partnership expanded Sonara to BHG's three South Carolina locations (Charleston, Aiken, Spartanburg).

9Chestnut Health Systems
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Research collaborator on ROME study. Chestnut Health Systems is a healthcare organization providing addiction treatment and research services.

sonarahealth.com
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Research collaborator on ROME study. Family Guidance provides behavioral health and addiction treatment services.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Partnership to expand access to take-home methadone for qualifying patients through UAMS's treatment programs.

Recent move12 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
1Ophelia Health
TypeDirect peer
Description

Virtual OUD treatment provider offering telehealth-based medication-assisted treatment, including for opioid use disorder. Overlaps directly with Sonara on the goal of expanding access to MAT via technology, though Ophelia's primary medication focus is buprenorphine.

TypeDirect peer
Description

Telehealth provider for opioid use disorder treatment, primarily prescribing buprenorphine. Competes with Sonara in the digital OUD treatment space and targets similar patient and payer audiences, though focused on buprenorphine rather than methadone.

TypeDirect peer
Description

Virtual substance use disorder treatment platform offering medication-assisted treatment and counseling. Direct competitor in telehealth OUD care with a similar mission of modernizing addiction treatment delivery.

TypeDirect peer
Description

Outpatient addiction and mental health provider with both in-person clinics and virtual care, including MAT. Comparable hybrid care model serving OUD patients and competing for similar payer and value-based contracts.

TypeDirect peer
Description

Digital substance use management platform sold to employers and health plans, covering alcohol, tobacco, and opioid use. Comparable in employer/payer channel and digital-first substance use treatment, though broader in scope than Sonara's methadone focus.

TypeDirect peer
Description

Telehealth addiction treatment provider offering medication-assisted treatment and counseling. Directly comparable in delivering MAT virtually to patients with opioid use disorder, including partnerships with OTPs and payers.

TypeDirect peer
Description

Outpatient opioid addiction treatment provider combining group therapy with MAT, including buprenorphine. Comparable in delivering community-based OUD treatment and competing for value-based payer contracts in the same domain.

TypeEmerging player
Description

Telehealth addiction and mental health treatment provider focused on MAT for opioid use disorder. Smaller and more niche than Ophelia/Bicycle but competes for the same virtual OUD treatment market, including partnerships with OTPs.

TypeEmerging player
Description

Digital health platform focused on substance use recovery support, including remote saliva testing, rewards-based adherence, and care navigation. Adjacent in remote monitoring of substance use behavior and supporting OTPs in adherence tracking.

TypeEmerging player
Description

Telehealth provider for substance use disorder treatment, including opioid addiction. Comparable in online counseling and MAT delivery to individuals, competing for the same virtual OUD treatment demand.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers8 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability4 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance3 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds5 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors8 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Sonara Health

Opioid Treatment Softwaresonarahealth.com

Sonara Health operates a HIPAA-compliant, FDA Class I-registered telehealth platform that enables opioid treatment programs (OTPs) to remotely observe methadone dosing for patients with opioid use disorder. The patented tamper-evident system allows OTPs to safely expand take-home dosing, currently deployed at 40+ sites across 14 states via partnerships with major OTP chains and state-government funding.

What Sonara Health does

Sonara Health is a Dallas-based healthcare technology company founded in 2020 that operates a HIPAA-compliant, FDA Class I-registered telehealth platform enabling remote observed dosing of methadone for patients with opioid use disorder (OUD). The platform combines a patented tamper-evident medication label with a patient-facing web application (Virtual Dosing Window™), a clinician dashboard for asynchronous video review and adherence tracking, and a suite of hybrid care tools (telecounseling, secure messaging, remote intake). An optional Measurement-Based Care (MBC) module supports structured clinical decision-making and is being validated through NIDA-funded research.

The company's primary customers are federally-licensed Opioid Treatment Programs (OTPs), which subscribe to the platform to issue take-home methadone doses with remote clinical oversight rather than requiring daily in-person visits. Sonara's distribution is anchored by channel partnerships with the largest U.S. OTP chains — including Behavioral Health Group, BayMark Health Services, Community Medical Services, and MedMark — alongside direct sales to individual clinics, and is increasingly supported by payer- and state-government-funded deployment models using Medicaid MCO contracts (CareSource), state opioid settlement funds (Pennsylvania, New Jersey FY25 budget), and grants.

Sonara generates revenue primarily through multi-year SaaS subscriptions sold to OTPs on a quote-based enterprise pricing model, augmented by grant and payer-funded deployment arrangements. The company has raised approximately $10.9M in equity across multiple rounds between 2021 and 2025 from impact-oriented investors including Mark Cuban, Acumen America, First Trust Capital Partners, Boomerang Ventures, and Blue Cross Blue Shield of Kansas, plus $2.5M in non-dilutive NIDA SBIR funding. Operational scale as of late 2024–early 2025 includes 40+ OTP locations across 14 states, 200,000+ cumulative methadone doses recorded on the platform, and a reported 30x revenue increase since launch.

Sonara Health firmographics

Firmographics
Name
Sonara Health
Legal name
Sonara Health, Inc.
Website
https://sonarahealth.com
Company type
Private
Founded year
2020
Operating status
Operating
Headcount range
11–50 employees
Short description
Sonara Health operates a HIPAA-compliant, FDA Class I-registered telehealth platform that enables opioid treatment programs (OTPs) to remotely observe methadone dosing for patients with opioid use disorder. The patented tamper-evident system allows OTPs to safely expand take-home dosing, currently deployed at 40+ sites across 14 states via partnerships with major OTP chains and state-government funding.
Ownership category
akta.pro rank

Sonara Health industry classification

Industry
Product category
Opioid Treatment Software
NAICS
Outpatient Mental Health and Substance Abuse Centers (621420), Offices of Physicians (6211)
SIC
Services-Health Services (8000)
akta.pro industry
PRIMARYHLAFACAG
Medication-Assisted Treatment (MAT) & Opioid Treatment Programs (OTPs)
Healthcare & Life Sciences/Healthcare Providers & Systems/Behavioral Health & Substance Use Treatment
SECONDARYHLACAFAD
Behavioral Health & Substance Use Remote Monitoring
Healthcare & Life Sciences/Digital Health & Health IT/Remote Patient Monitoring (RPM) & Connected Care Platforms
SECONDARYHLALAIAM
Controlled-Substance & High-Risk Medication Teleprescribing Platforms (compliance-focused)
Healthcare & Life Sciences/Telehealth Platforms/Pharmacy-Integrated Telehealth & ePrescribing Platforms

Keywords

  • Opioid treatment platform
  • Methadone remote dosing
  • Telehealth medication monitoring
  • Addiction treatment software
  • Hybrid care platform

Where Sonara Health is headquartered

Location

Headquarters

HQ city
Dallas
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Sonara Health business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Technology or R&D, Personnel, Marketing or Sales, Operations, Infrastructure

Revenue model

  1. SaaS Platform Subscription: Sonara provides its remote medication monitoring platform to OTPs on a subscription basis. OTPs pay for access to the platform to enable their patients to record take-home methadone doses remotely. Revenue is recurring as OTPs subscribe to use the platform for their patient population.
  2. Partnership Funding: Sonara partners with healthcare payers (CareSource) and state governments (New Jersey) to fund platform deployment at partner OTPs, particularly using opioid settlement funds. This creates alternative revenue streams through grants and payer contracts.

Pricing tiers

ModelBillingPrice
SubscriptionMulti-year contractEnterprise pricing for OTP partners - quote-based

Go-to-market motion2 records

Distribution channels3 records

Marketing channels6 records

Sonara Health product offering

Product offering

Core offering

Sonara Health develops a HIPAA-compliant, FDA Class I Medical Device telehealth platform that enables federally-licensed opioid treatment programs (OTPs) to remotely observe and verify patient self-administration of methadone at home. The platform combines a patient-facing Virtual Dosing Window app (QR code scanning plus video recording of each dose), a clinician dashboard for asynchronous adherence review, and hybrid care tools (telecounseling, secure messaging, remote intake) to reduce daily in-person clinic visits while maintaining regulatory compliance.

Product overview

Sonara Health offers a hybrid care platform for opioid treatment programs (OTPs) consisting of three integrated core products: the Virtual Dosing Window™ (patient-facing app for remote methadone dosing via QR scanning and video recording), Hybrid Care Tools (telehealth suite including remote intake, telecounseling, and messaging), and the Clinician Platform (care team dashboard for video review and patient monitoring). The platform includes a patented tamper-aware medication adherence system with QR codes, enabling patients to record methadone doses at home while care teams review remotely. An optional Measurement-Based Care (MBC) tool integrates assessment capabilities. The complete system is available via the sonara.app portal.

Differentiator

Problem solved

Functional benefit

Products and services

  • Virtual Dosing Window™ Patient-facing web application that enables individuals in methadone treatment programs to record their daily methadone dose from home. Patients scan a tamper-aware QR code on their medication bottle and record a short video of themselves taking the dose, which is sent to their OTP care team for asynchronous review. Designed for opioid treatment programs (OTPs) and their patients with opioid use disorder.
  • Clinician Platform

Quantifiable outcome

  • 85% of take-home methadone doses taken as prescribed on platform
  • +6 more outcomes

Companies that use Sonara Health

Customer profile

Named customers8 records

Segments3 records

Ideal customer profiles2 records

Sonara Health technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability4 records

Feature5 records

Sonara Health partnerships and signals

Strategic signal

Partnerships

Eleven partnerships are on record, tiered core and minor.

  • MedMark Treatment CenterscoreStrategic or Co-development Partner · 7 March 2025MedMark's Washington clinic partnership expanded to Pennsylvania using state opioid settlement funds. Partnership makes remote dosing platform available to Pennsylvania patients.
  • Community Medical Services (CMS)coreStrategic or Co-development Partner · 7 May 2024CMS operates 73 clinics across 11 states treating 24,000 patients daily. Partnership makes Sonara available at four CMS clinics in Ohio (Cleveland, Lima, Columbus, Kettering), funded by CareSource.
  • BayMark Health ServicescoreStrategic or Co-development Partner · 11 March 2024BayMark operates opioid treatment programs across multiple states. Partnership enables Sonara's remote dosing platform at BayMark Ohio clinics. Dave White, BayMark CEO, noted the partnership enables safe take-home dosing for patients.
  • CareSourcecoreStrategic or Co-development Partner · 11 March 2024Nonprofit health plan that provided funding to enable Sonara deployment at BayMark Ohio clinics. CareSource is a Medicaid managed care organization committed to addressing gaps in behavioral health care for members.
  • Central Florida Treatment CentercoreStrategic or Co-development Partner · 29 January 2024Treatment center operating since 1983 in Orlando area. Partnership makes Sonara the 10th state for remote dosing platform availability.
  • SouthEast Alaska Regional Health Consortium (SEARHC)coreStrategic or Co-development Partner · 22 January 2024One of the largest Native-run healthcare organizations in the US serving 27 communities in Southeast Alaska. Partnership brings Sonara to eligible patients in Klawock, Sitka, and Juneau.
  • New Jersey Association for the Treatment of Opioid Dependence (NJATOD)coreStrategic or Co-development Partner · 1 January 2024Partnership with NJATOD and Assemblyman William F. Moen Jr. to administer state-funded remote observation pilot program for take-home methadone included in NJ FY25 budget.
  • Behavioral Health Group (BHG)coreStrategic or Co-development Partner · 28 December 2023BHG operates the largest network of Joint Commission-accredited OTPs in 22 states. Partnership expanded Sonara to BHG's three South Carolina locations (Charleston, Aiken, Spartanburg).
  • Chestnut Health SystemsminorStrategic or Co-development PartnerResearch collaborator on ROME study. Chestnut Health Systems is a healthcare organization providing addiction treatment and research services.
  • Family Guidance, Inc.minorStrategic or Co-development PartnerResearch collaborator on ROME study. Family Guidance provides behavioral health and addiction treatment services.
  • University of Arkansas for Medical SciencescoreStrategic or Co-development PartnerPartnership to expand access to take-home methadone for qualifying patients through UAMS's treatment programs.

Scale indicators7 records

Recent moves12 records

Expansion highlights6 records

Sonara Health competitors and assessment

Company assessment

Direct peers

  • Ophelia Health: Virtual OUD treatment provider offering telehealth-based medication-assisted treatment, including for opioid use disorder. Overlaps directly with Sonara on the goal of expanding access to MAT via technology, though Ophelia's primary medication focus is buprenorphine.
  • Bicycle Health: Telehealth provider for opioid use disorder treatment, primarily prescribing buprenorphine. Competes with Sonara in the digital OUD treatment space and targets similar patient and payer audiences, though focused on buprenorphine rather than methadone.
  • Workit Health: Virtual substance use disorder treatment platform offering medication-assisted treatment and counseling. Direct competitor in telehealth OUD care with a similar mission of modernizing addiction treatment delivery.
  • Eleanor Health: Outpatient addiction and mental health provider with both in-person clinics and virtual care, including MAT. Comparable hybrid care model serving OUD patients and competing for similar payer and value-based contracts.
  • Pelago (formerly Quit Genius): Digital substance use management platform sold to employers and health plans, covering alcohol, tobacco, and opioid use. Comparable in employer/payer channel and digital-first substance use treatment, though broader in scope than Sonara's methadone focus.
  • PursueCare: Telehealth addiction treatment provider offering medication-assisted treatment and counseling. Directly comparable in delivering MAT virtually to patients with opioid use disorder, including partnerships with OTPs and payers.
  • Groups Recover Together: Outpatient opioid addiction treatment provider combining group therapy with MAT, including buprenorphine. Comparable in delivering community-based OUD treatment and competing for value-based payer contracts in the same domain.

Emerging players

  • Bright Heart Health: Telehealth addiction and mental health treatment provider focused on MAT for opioid use disorder. Smaller and more niche than Ophelia/Bicycle but competes for the same virtual OUD treatment market, including partnerships with OTPs.
  • DynamiCare Health: Digital health platform focused on substance use recovery support, including remote saliva testing, rewards-based adherence, and care navigation. Adjacent in remote monitoring of substance use behavior and supporting OTPs in adherence tracking.
  • Lionrock Recovery: Telehealth provider for substance use disorder treatment, including opioid addiction. Comparable in online counseling and MAT delivery to individuals, competing for the same virtual OUD treatment demand.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Sonara Health social profiles

Digital presence

Sonara Health compliance and trust

Trust signal

Compliance3 records

Sonara Health financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Sonara Health leadership team

Management profile

Number of profiles

Profiles1 record

Sonara Health funding detail

Funding detail

Funding overview

Funding rounds5 records

Investors8 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Sonara Health M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Sonara Health

What does Sonara Health do?

Sonara Health develops a HIPAA-compliant, FDA Class I Medical Device telehealth platform that enables federally-licensed opioid treatment programs (OTPs) to remotely observe and verify patient self-administration of methadone at home. The platform combines a patient-facing Virtual Dosing Window app (QR code scanning plus video recording of each dose), a clinician dashboard for asynchronous adherence review, and hybrid care tools (telecounseling, secure messaging, remote intake) to reduce daily in-person clinic visits while maintaining regulatory compliance.

Is Sonara Health a public or private company?

Sonara Health is a private company. It is classified as venture growth investor backed and is currently operating.

When was Sonara Health founded?

Sonara Health was founded in 2020. It employs 11 to 50 people.

Where is Sonara Health based?

Sonara Health is headquartered in Dallas, United States, in the North America region.

How does Sonara Health make money?

Two revenue lines are on record. SaaS Platform Subscription is the primary driver. The others are partnership Funding.

Who are Sonara Health's main competitors?

Direct peers on record are Ophelia Health, Bicycle Health, Workit Health, Eleanor Health, Pelago (formerly Quit Genius), PursueCare and Groups Recover Together. Emerging players are Bright Heart Health, DynamiCare Health and Lionrock Recovery.

Does Sonara Health have an API?

No public API is recorded for Sonara Health.

What industry is Sonara Health in?

Sonara Health's product category is Opioid Treatment Software. Its primary akta.pro industry code is HLAFACAG, Medication-Assisted Treatment (MAT) & Opioid Treatment Programs (OTPs), with a secondary code of HLACAFAD, Behavioral Health & Substance Use Remote Monitoring. Its NAICS code is 621420 and its SIC code is 8000.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
citybizBoomerang Ventures Invests $1M In Sonara HealthBoomerang Ventures announced a $1 million strategic investment in Sonara Health, a Dallas-based health technology company that operates a hybrid care platform for opioid treatment programs. The funding is part of Sonara's latest investment round, which also included other impact investors including Acumen America, Sorenson Impact Foundation, Oakwood Circle Ventures, Royal Street Ventures, and First Trust Capital Partners. Since launching in late-2022, Sonara Health has supported over 4,200 patients across more than 50 clinics in 14 states, with patients averaging 14 additional take-home doses per month and payers reporting an estimated 10.75x ROI.Pulse 2.0Sonara: Strategic Investment Raised For Methadone Treatment PlatformSonara, a hybrid methadone treatment platform, raised new funding from Acumen America and the Sorenson Impact Foundation. The platform supports over 1,000 patients across 50 clinics, offering virtual dosing and telecounseling. It aims to scale equitable, tech-enabled methadone care nationwide.PrwebSonara Secures Strategic Investment to Expand Hybrid Care for Methadone Treatment to Modernize Methadone ClinicsSonara, a hybrid care platform for methadone treatment, has closed a strategic investment round with participation from Acumen America, Sorenson Impact Foundation, Oakwood Circle Ventures, Boomerang Ventures, and existing investor First Trust Capital Partners. The funding will support expansion of Sonara's Virtual Dosing Window platform, which enables remote observed dosing and telecounseling for patients with opioid use disorder. Since launching in late 2022, Sonara has served over 1,000 patients across 50 clinics in 14 states, with clinics reporting a 10.75x return on investment and patients receiving an average of 14 additional take-home methadone days per month.PR NewswireSonara Health Continues Expansion of Remote Methadone Treatment With $2.5M Grant From NIDASonara Health received a $2.5M NIDA grant to fund Phase II of its Remote Observed Methadone Evaluation study, which began October 7, 2024. The study will assess treatment retention, cost, and effectiveness, while New Jersey allocated FY25 budget funding for a remote observation pilot. Sonara plans to integrate remote intakes, tele-counseling, and generative AI.outsourcing-pharma.comInnovative approaches to opioid use disorder treatmentA report on opioid settlement funds recommends evidence-based treatment innovations, including remote methadone dosing and expanded buprenorphine access. It highlights addressing social determinants and culturally relevant care, citing examples like the Mi'kmaq Nation's sweat lodge and South Carolina's funding for Sonara Health's Virtual Dosing Window.outsourcing-pharma.comOvercoming barriers to opioid treatment: Challenges and innovations in methadone and buprenorphineSheeba Ibidunni, VP of operations at Sonara Health, discusses barriers to methadone and buprenorphine access, including provider biases, waitlists, and state Medicaid restrictions. She highlights remote observation of take-home methadone as a promising intervention and urges reimbursement for such services.PR NewswireSonara Health Partners with Community Medical Services to Increase Methadone Access in OhioSonara Health has partnered with Community Medical Services to deploy its remote dosing application for take-home methadone at four CMS clinics in Ohio, with funding from nonprofit health plan CareSource. Eligible patients at the Kettering, Lima, Columbus on High, and Cleveland on Carnegie locations can now record and submit video confirmation of their take-home doses for care team review, reducing the need for daily in-person visits. The partnership is designed to help patients qualify for take-homes sooner and improve treatment retention rates while expanding access to opioid use disorder treatment.American City Business JournalsSonara Health, BayMark Health Services and CareSource announce partnershipSonara Health, BayMark Health Services, and CareSource announced a partnership to provide remote dosing technology for opioid treatment in Dayton and Amherst. The collaboration, funded by CareSource, makes Sonara's web-based application available to eligible patients, aiming to increase access to methadone take-home doses. Sonara is now available in eleven states with plans to expand in 2024.PR NewswireSonara Health Awarded NIH Funding to Fight the Opioid CrisisSonara Health, a Mark Cuban-backed health-tech company, was awarded a $267,861 SBIR Phase I grant from the National Institutes of Health's National Institute on Drug Abuse to further develop its Medication Monitoring System for take-home methadone treatment. The grant, under award number 1R43DA056259-01, will fund the Remotely Observed Methadone Evaluation (ROME) project in collaboration with Oregon Health and Science University and Adapt, Inc. to combat the opioid epidemic that caused over 100,000 deaths in 2021. This marks Sonara Health's first grant funding and builds on prior research showing the web platform improved quality of life for patients and was found feasible and safe by providers.Dallas InnovatesMark Cuban-Backed Opioid Recovery Startup Sonara Health Raises $3M for Medication Monitoring Platform » Dallas InnovatesDallas-based startup Sonara Health has secured a $3 million seed funding round, bringing its total capital raised to $5 million. The company, which holds a recent patent for a take-home methadone monitoring system, aims to reduce barriers to opioid addiction treatment by allowing patients to verify medication intake via a telehealth app. Backed by investors including First Trust Capital Partners and Blue Cross Blue Shield of Kansas, Sonara plans to expand partnerships with treatment programs in multiple states.